Vaccinex (VCNX) shares will be delisted from the Nasdaq stock exchange on Wednesday after the company failed to comply with the exchange's rule of maintaining a minimum of $2.5 million in stockholders' equity, Vaccinex said Tuesday, citing a notification from the exchange.
Shares slumped 62% following a jump in intraday trading volume to over 618,000 from a daily average of about 110,000.
Reviva Pharmaceuticals Holdings (RVPH) said late Monday it priced an offering of 12 million shares along with series A warrants and series B warrants at $1.50 per share and accompanying warrants for gross proceeds of about $18 million.
Shares sank 39%, with intraday trading volume climbing to over 15.1 million versus a daily average of about 1.33 million.
Amentum (AMTM) reported a year-over-year decline late Monday in fiscal Q4 proforma non-GAAP net income and revenue.
Shares slumped 10%, with intraday trading volume at over 3.02 million versus a daily average of about 2.45 million.
Price: 1.43, Change: -2.29, Percent Change: -61.56
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。